Mercado mundial de pruebas hereditarias: tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado de pruebas hereditarias

Se prevé que el mercado de las pruebas hereditarias se expanda significativamente en los próximos años debido al aumento del cáncer y las enfermedades genéticas, así como al mayor conocimiento y aceptación de la terapia personalizada. La farmacogenómica, a menudo conocida como pruebas de fármacos y genes, ha utilizado con frecuencia las pruebas hereditarias. Se prevé que las mejoras en los métodos de pruebas genéticas aceleren la expansión del mercado.

Data Bridge Market Research analiza que el mercado de pruebas hereditarias, que fue de USD 1.90 mil millones en 2021, se disparará hasta USD 3.83 mil millones para 2029, y se espera que experimente una CAGR del 9,15% durante el período de pronóstico de 2022 a 2029. Además de los conocimientos del mercado, como el valor de mercado, la tasa de crecimiento, los segmentos del mercado, la cobertura geográfica, los actores del mercado y el escenario del mercado, el informe de mercado curado por el equipo de Data Bridge Market Research también incluye un análisis experto en profundidad, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado de pruebas hereditarias

Market Definition

In hereditary testing, particular inherited variations (variants) in a person's genes are changed. On the probability of contracting diseases, genetic variations might have negative, positive, neutral (no effect), or ambiguous effects. There is evidence that certain genes with harmful mutations enhance the likelihood of acquiring cancer. It is estimated that 5 to 10% of all malignancies are caused by these hereditary variations.

Hereditary Testing Market Dynamics

Drivers

• Increasing prevalence of hereditary cancer

Cancer is a genetic disorder produced due to definite changes in genes that administrate cell efficacy, mainly moving their growth and duplication. Hereditary genetic mutations are the reason of ~5–10% of all cancers. The detectives have related mutations in precise genes with added 50 hereditary cancer syndromes which effects entities in emerging certain cancers.

• Development in genomic technology

Breast cancer is one of the most collective cancers in the world affecting almost 12.5% of women during their lifetime and 5%–10% of these patients have a hereditary form. BRCA1 and BRCA2 genes are the two most mutual mutated genes, but additional genes connected with hereditary breast cancer are emerging. New developments in genomic skills have directed to parallel testing of multiple genes.

Opportunities

Mutation in the genes is one factor that impacts the early detection of hereditary cancer, increasing market growth. At the same time, efficacy and cost-effectiveness over traditional testing methods also drive market growth. Moreover, mounting demand for initial discovery and precise analysis is a feature that drives market growth.

Restraints/Challenges

The performance of hereditary multigene panel testing raises several issues, such as the measures that the patients have to meet to undertake the test and the patient’s clinical association, which will obstruct the market growth.

This hereditary testing  market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hereditary testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Hereditary Testing Market

Many of the industries across the world have been harmfully wedged over the last 18 months. This can be attributed to significant disturbances experienced by their respective industrialized and supply-chain processes as a result of various precautionary lockdowns and other restrictions governing establishments across the globe enforced. Furthermore, consumer demand has also subsequently reduced as persons are now more keen on eradicating non-essential expenses from their respective budgets. Most persons' general economic status has been severely affected by this outbreak. These aforementioned elements are predictable to burden the revenue trajectory of the global hereditary testing market over the forecast timeline.

Recent Development

• In June 2020, Invitae and ArcherDX announced Monday morning that the two genetic testing companies have agreed to syndicate in command to expand their footmark in the cancer genetics and precision oncology space.

Global Hereditary Testing Market Scope

The hereditary testing market is segmented on the basis of type, indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

 Type

• Multi Panel Test
• Single-site Genetic Test

Indication

• Breast Cancer
• Ovarian Cancer
• Colorectal Cancer
• Others

End-user

• Diagnostic Laboratory
• Hospitals
• Others

Hereditary Testing Market Regional Analysis/Insights

The hereditary testing market is analysed and market size insights and trends are provided by country, type, indication and end user as referenced above.

The countries covered in the hereditary testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America, the market is dominates the market owing to rising throwaway revenue, availability of advanced healthcare infrastructure, and increasing adoption of genetic testing in the region.

Asia-Pacific and Europe are expected to a significant growth rate in the coming years due to growing cancer cases and developing healthcare sectors.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The hereditary testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hereditary testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hereditary testing market. The data is available for historic period 2010-2020.

Competitive Landscape and Hereditary Testing Market Share Analysis

The hereditary testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to hereditary testing market.

Some of the major players operating in the hereditary testing market are:

• CENTOGENE N.V. ( Germany)
• Ambry Genetics (U.S.)
• Myriad Genetics, Inc.  (U.S.)
• NeoGenomics Laboratories (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• PreventionGenetics (U.S.)
• Fulgent Genetics (U.S.)
• Invitae Corporation (U.S.)
• Laboratorios de diagnóstico médico, LLC (Estados Unidos)
• Natera (Estados Unidos)
• Caris Life Sciences (Estados Unidos)
• LabSolutions (Estados Unidos)
• Progenity Inc. (Estados Unidos)
• Laboratorios ARUP (EE.UU.)

SKU-53007